Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
暂无分享,去创建一个
L. Pusztai | A. Grothey | Z. Demko | S. Kopetz | T. Powles | M. Malhotra | J. Taieb | T. Yoshino | Bob T. Li | P. Kasi | G. Fehringer | N. Starling | A. Aleshin | H. Taniguchi | V. Aushev | E. Kalashnikova | D. Cunningham | D. Kotani | Shruti Sharma | P. Billings | Angel Rodriguez | Y. Nakamura